Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advana Science
New Biotechnology Scientific Discoveries in Cognitive Health Ready for Nutraceutical Application
October 31st, 2008
Advana Science will unveil new biotechnology scientific discoveries in beta amyloid plaque reduction linked to major degenerative diseases, including Alzheimer's disease and Type 2 diabetes for nutraceutical application. This safe, natural compound offers unprecedented opportunities for nutraceutical companies seeking science-based solutions for consumers. Peter Leighton, CEO, Advana Science will present these new developments at the leading ingredient supplier meeting; Supply Side West in Las Vegas on October 24th at booth# 10056 at 1:30 pm PT. Alzheimer's disease is characterized by the brain accumulation of aggregates and insoluble fibrillar deposits that contain a...
Source: Health Business Week (2008-10-31)
|
